文献速递关节外科

氨甲环酸降低无菌性翻修关节置换术后假体周围关节感染发生率

Tranexamic Acid Reduces the Rate of Periprosthetic Joint Infection After Aseptic Revision Arthroplasty.
PubMed 文献 · J Bone Joint Surg Am · 2020-01-01

基于单中心前瞻性维护数据库,2009至2018年因无菌性失败行翻修全关节置换术且随访至少90天的1731例患者中,83例(4.8%)发生假体周围关节感染(PJI)。接受氨甲环酸(TXA)者PJI发生率为3.30%,显著低于未接受TXA者的5.73%(p=0.029);多因素分析显示TXA为独立保护因素(OR 0.47,95%CI 0.23-0.90,p=0.030)。

要点

  • 无菌性翻修全关节置换术后PJI总体发生率为4.8%(83/1731)。
  • 接受TXA者PJI发生率为3.30%,未接受TXA者为5.73%(p=0.029)。
  • 多因素分析中TXA为PJI独立保护因素(OR 0.47,95%CI 0.23-0.90,p=0.030)。

核心结论

  • 在单中心开展的本研究中,无菌性翻修关节置换术中使用TXA经多因素校正患者特征和手术因素后,与后续急性PJI风险降低独立相关。

研究设计与样本

  • 使用前瞻性维护的机构数据库,纳入2009至2018年因无菌性失败行翻修全关节置换术且随访至少90天的患者。
  • 共识别1731例无菌性翻修患者,其中83例(4.8%)发生PJI,所有PJI患者均符合肌肉骨骼感染学会(MSIS)标准。
  • 采用多因素分析识别与无菌性翻修全关节置换术后PJI独立相关的变量。
  • 证据等级:治疗性III级。

主要发现

  • 接受TXA者术后PJI发生率为3.30%,未接受TXA者为5.73%,差异有统计学意义(p=0.029)。
  • 校正相关混杂变量后,TXA仍为PJI的独立保护因素(OR 0.47,95%CI 0.23-0.90,p=0.030)。
  • 女性为PJI的独立保护因素(OR 0.52,95%CI 0.30-0.88,p=0.016)。
  • 术前贫血与后续PJI风险升高独立相关(OR 2.37,95%CI 1.34-4.16,p=0.003)。

关键数值与推荐

  • PJI判定采用肌肉骨骼感染学会(MSIS)标准。
  • 接受TXA者PJI发生率为3.30%,未接受TXA者为5.73%(p=0.029)。
  • TXA与PJI的OR为0.47(95%CI 0.23-0.90,p=0.030)。
  • 女性与PJI的OR为0.52(95%CI 0.30-0.88,p=0.016)。
  • 术前贫血与PJI的OR为2.37(95%CI 1.34-4.16,p=0.003)。

临床怎么用

  • 原文结论为无菌性翻修关节置换术中使用TXA与后续急性PJI风险降低独立相关,原文未据此给出具体用药推荐。

局限性

  • 原文结论明确说明本研究为单中心开展。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Revision total joint arthroplasty (TJA) has a higher rate of periprosthetic joint infection (PJI) compared with primary TJA, possibly as the result of increased allogeneic blood transfusion. Tranexamic acid (TXA) is gaining popularity in revision TJA to minimize blood loss and the need for transfusion; however, its effect on PJI reduction has yet to be investigated. The hypothesis of this study was that the administration of TXA during revision arthroplasty is protective against subsequent PJI. METHODS: A prospectively maintained institutional database was used to identify patients who underwent revision TJA for aseptic failure from 2009 to 2018 and had a minimum follow-up of 90 days. Patients who developed PJI following revision arthroplasty were identified. All patients with PJI met Musculoskeletal Infection Society (MSIS) criteria. A multivariate analysis was performed to identify variables independently associated with PJI after aseptic revision TJA. RESULTS: Overall, 1,731 patients who underwent aseptic revision were identified; of these patients, 83 (4.8%) developed PJI. Patients who received TXA had significantly lower rates (p = 0.029) of PJI postoperatively at 3.30% compared with those who did not receive TXA at 5.73%. After controlling for relevant confounding variables, TXA remained a significant independent factor that protected against PJI (odds ratio [OR], 0.47 [95% confidence interval (CI), 0.23 to 0.90]; p = 0.030). Female sex was also identified as a significant independent factor that protected against PJI (OR, 0.52 [95% CI, 0.30 to 0.88]; p = 0.016). However, preoperative anemia was independently associated with an increased risk of subsequent PJI (OR, 2.37 [95% CI, 1.34 to 4.16]; p = 0.003). CONCLUSIONS: Based on this study conducted at a single institution, the use of TXA during aseptic revision arthroplasty was independently associated with a reduced risk of subsequent acute PJI after adjusting for multiple patient characteristics and surgical factors. LEVEL OF EVIDENCE: Therapeutic Level III. See Instructions for Authors for a complete description of levels of evidence.

来源:J Bone Joint Surg Am,查看原文。版权归原作者所有。

引用

  1. Klement MR, Padua FG, Li WT, et al. Tranexamic Acid Reduces the Rate of Periprosthetic Joint Infection After Aseptic Revision Arthroplasty. J Bone Joint Surg Am. 2020. PMID: 32769601. doi:10.2106/JBJS.19.00925

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。